Haoyu Wu

701 total citations
36 papers, 458 citations indexed

About

Haoyu Wu is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Haoyu Wu has authored 36 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Haoyu Wu's work include Lipoproteins and Cardiovascular Health (4 papers), Adenosine and Purinergic Signaling (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Haoyu Wu is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Adenosine and Purinergic Signaling (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Haoyu Wu collaborates with scholars based in China, United Kingdom and Canada. Haoyu Wu's co-authors include Kun Ma, Bai‐Xiang Li, Vincenzo Forgetta, J. Brent Richards, Sirui Zhou, Peng Li, Bowen Lou, Celia M.T. Greenwood, Tianyuan Lu and Jianqing She and has published in prestigious journals such as Circulation Research, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Haoyu Wu

33 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haoyu Wu China 16 132 75 71 59 53 36 458
Mona G. Amer Egypt 12 126 1.0× 81 1.1× 32 0.5× 31 0.5× 26 0.5× 34 518
Ming‐Tsai Chiang Taiwan 13 330 2.5× 52 0.7× 38 0.5× 40 0.7× 16 0.3× 18 499
Hao Dai China 12 238 1.8× 80 1.1× 72 1.0× 29 0.5× 25 0.5× 32 492
Ching‐Wan Lam Hong Kong 14 237 1.8× 64 0.9× 95 1.3× 20 0.3× 50 0.9× 32 593
Xue Geng China 12 324 2.5× 65 0.9× 25 0.4× 74 1.3× 19 0.4× 34 613
Clintoria R. Williams United States 14 172 1.3× 44 0.6× 13 0.2× 52 0.9× 49 0.9× 32 517
Syeda H Afroze United States 11 133 1.0× 80 1.1× 18 0.3× 24 0.4× 18 0.3× 23 419
Carolina Victória Cruz Junho Brazil 14 207 1.6× 39 0.5× 48 0.7× 101 1.7× 10 0.2× 24 533
Jessica Gutiérrez United States 7 216 1.6× 44 0.6× 87 1.2× 29 0.5× 13 0.2× 17 459
Małgorzata Małodobra-Mazur Poland 15 172 1.3× 95 1.3× 35 0.5× 30 0.5× 18 0.3× 38 526

Countries citing papers authored by Haoyu Wu

Since Specialization
Citations

This map shows the geographic impact of Haoyu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyu Wu more than expected).

Fields of papers citing papers by Haoyu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoyu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyu Wu. The network helps show where Haoyu Wu may publish in the future.

Co-authorship network of co-authors of Haoyu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Haoyu Wu. A scholar is included among the top collaborators of Haoyu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoyu Wu. Haoyu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Haoyu, Aziz Atamanov, Tom Bundervoet, & Pierella Paci. (2024). Is economic growth less welfare enhancing in Africa? Evidence from the last forty years. World Development. 184. 106759–106759.
2.
Wu, Haoyu, David A. Stephens, & Erica E. M. Moodie. (2024). An SIR‐based Bayesian framework for COVID‐19 infection estimation. Canadian Journal of Statistics. 52(4). 1 indexed citations
3.
Fan, Lin, Ming Yang, Yutong Han, et al.. (2024). Drug recommendation for optimization on treatment outcome for MDR/RR-TB based on a multi-center, large scale, retrospective cohort study in China. Expert Review of Anti-infective Therapy. 22(5). 353–363. 1 indexed citations
4.
Yuan, Yu, Kaixuan Lin, Haoyu Wu, et al.. (2024). Targeting senescent cells in aging and COVID-19: from cellular mechanisms to therapeutic opportunities. Cell Regeneration. 13(1). 1 indexed citations
5.
6.
Min, Xin, et al.. (2023). Synthesis and biological evaluation of resveratrol amide derivatives as selective COX-2 inhibitors. Chemico-Biological Interactions. 380. 110522–110522. 14 indexed citations
7.
Lou, Bowen, Haoyu Wu, Katrin Bennewitz, et al.. (2023). Increased circulating uric acid aggravates heart failure via impaired fatty acid metabolism. Journal of Translational Medicine. 21(1). 199–199. 15 indexed citations
8.
Lou, Bowen, Haoyu Wu, Hui Liu, et al.. (2022). Association between Cystatin C and Cardiac Function in Acute Myocardial Infarction Patients: A Real-World Analysis. Disease Markers. 2022. 1–12. 5 indexed citations
9.
Wang, Chen, Jianyu Zhang, Ming He, et al.. (2022). MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension. Circulation Research. 131(10). 828–841. 22 indexed citations
10.
Lou, Bowen, Hui Liu, Haoyu Wu, et al.. (2022). In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction. Lipids in Health and Disease. 21(1). 105–105. 9 indexed citations
11.
Wang, Chen, Haoyu Wu, Yulan Ye, et al.. (2022). Endothelial-derived extracellular microRNA-92a promotes arterial stiffness by regulating phenotype changes of vascular smooth muscle cells. Scientific Reports. 12(1). 344–344. 30 indexed citations
12.
Zhou, Bo, Haoyu Wu, Chen Wang, Bowen Lou, & Jianqing She. (2021). Impact of Age, Sex, and Renal Function on the Efficacy and Safety of Direct Oral Anticoagulants vs. Vitamin K Antagonists for the Treatment of Acute Venous Thromboembolism: A Meta-Analysis of 22,040 Patients. Frontiers in Cardiovascular Medicine. 8. 700740–700740. 4 indexed citations
13.
Lou, Bowen, et al.. (2021). Interplay Between Gut Microbiota and Amino Acid Metabolism in Heart Failure. Frontiers in Cardiovascular Medicine. 8. 752241–752241. 12 indexed citations
14.
Wang, Chen, Haoyu Wu, Bowen Lou, et al.. (2021). Targeted metabolomic analysis of plasma fatty acids in acute myocardial infarction in young adults. Nutrition Metabolism and Cardiovascular Diseases. 31(11). 3131–3141. 21 indexed citations
15.
Lu, Tianyuan, Vincenzo Forgetta, Haoyu Wu, et al.. (2021). A Polygenic Risk Score to Predict Future Adult Short Stature Among Children. The Journal of Clinical Endocrinology & Metabolism. 106(7). 1918–1928. 18 indexed citations
16.
Wu, Haoyu, Chien‐Ting Pan, Sheng‐Nan Chang, et al.. (2021). Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report. Journal of the Formosan Medical Association. 120(9). 1777–1781. 3 indexed citations
17.
She, Jianqing, Bowen Lou, Hui Liu, et al.. (2021). ARNI Versus ACEI/ARB in Reducing Cardiovascular Outcomes After Myocardial Infarction. ESC Heart Failure. 8(6). 4607–4616. 21 indexed citations
18.
Lu, Tianyuan, Sirui Zhou, Haoyu Wu, et al.. (2020). Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening. Genetics in Medicine. 23(3). 508–515. 43 indexed citations
19.
Ma, Kun, Haoyu Wu, Peng Li, & Bai‐Xiang Li. (2018). LC3-II may mediate ATR-induced mitophagy in dopaminergic neurons through SQSTM1/p62 pathway. Acta Biochimica et Biophysica Sinica. 50(10). 1047–1061. 24 indexed citations
20.
Ma, Kun, Haoyu Wu, Bo Zhang, Xijing He, & Bai‐Xiang Li. (2015). Neurotoxicity effects of atrazine-induced SH-SY5Y human dopaminergic neuroblastoma cells via microglial activation. Molecular BioSystems. 11(11). 2915–2924. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona G. Amer Breakdown of academic impact, for papers by Ming‐Tsai Chiang Breakdown of academic impact, for papers by Hao Dai Breakdown of academic impact, for papers by Ching‐Wan Lam Breakdown of academic impact, for papers by Xue Geng Breakdown of academic impact, for papers by Clintoria R. Williams Breakdown of academic impact, for papers by Syeda H Afroze Breakdown of academic impact, for papers by Carolina Victória Cruz Junho Breakdown of academic impact, for papers by Jessica Gutiérrez Breakdown of academic impact, for papers by Małgorzata Małodobra-Mazur
Rankless by CCL
2026